Found 10 results
Author Title [ Type(Asc)] Year
Filters: Author is Depner, Christopher M  [Clear All Filters]
Journal Article
D. B. Jump, Depner, C. M., Tripathy, S., and Lytle, K. A., Potential for dietary ω-3 fatty acids to prevent nonalcoholic fatty liver disease and reduce the risk of primary liver cancer., Advances in nutrition (Bethesda, Md.), vol. 6, no. 6, pp. 694-702, 2015.
D. B. Jump, Lytle, K. A., Depner, C. M., and Tripathy, S., Omega-3 polyunsaturated fatty acids as a treatment strategy for nonalcoholic fatty liver disease., Pharmacol Ther, vol. 181, pp. 108-125, 2018.
D. B. Jump, Depner, C. M., and Tripathy, S., Omega-3 fatty acid supplementation and cardiovascular disease., Journal of lipid research, vol. 53, no. 12, pp. 2525-45, 2012.
C. M. Depner, Traber, M., Bobe, G., Kensicki, E., Bohren, K. M., Milne, G., and Jump, D. B., A metabolomic analysis of omega-3 fatty acid-mediated attenuation of western diet-induced nonalcoholic steatohepatitis in LDLR-/- mice., PLoS One, vol. 8, no. 12, p. e83756, 2013.
C. M. Depner, Torres-Gonzalez, M., Tripathy, S., Milne, G., and Jump, D. B., Menhaden oil decreases high-fat diet-induced markers of hepatic damage, steatosis, inflammation, and fibrosis in obese Ldlr-/- mice., The Journal of nutrition, vol. 142, no. 8, pp. 1495-503, 2012.
D. B. Jump, Depner, C. M., Tripathy, S., and Lytle, K. A., Impact of dietary fat on the development of non-alcoholic fatty liver disease in Ldlr-/- mice., Proc Nutr Soc, vol. 75, no. 1, pp. 1-9, 2016.
D. B. Jump, Tripathy, S., and Depner, C. M., Fatty acid-regulated transcription factors in the liver., Annu Rev Nutr, vol. 33, pp. 249-69, 2013.
K. A. Lytle, Depner, C. M., Wong, C. P., and Jump, D. B., Docosahexaenoic acid attenuates Western diet-induced hepatic fibrosis in Ldlr-/- mice by targeting the TGFβ-Smad3 pathway., J Lipid Res, vol. 56, no. 10, pp. 1936-46, 2015.
C. M. Depner, Philbrick, K. A., and Jump, D. B., Docosahexaenoic Acid Attenuates Hepatic Inflammation, Oxidative Stress, and Fibrosis without Decreasing Hepatosteatosis in a Ldlr-/- Mouse Model of Western Diet-Induced Nonalcoholic Steatohepatitis., The Journal of nutrition, 2013.
C. M. Depner, Philbrick, K. A., and Jump, D. B., Docosahexaenoic acid attenuates hepatic inflammation, oxidative stress, and fibrosis without decreasing hepatosteatosis in a Ldlr(-/-) mouse model of western diet-induced nonalcoholic steatohepatitis., J Nutr, vol. 143, no. 3, pp. 315-23, 2013.